MARLENE DEBEL - 19 Feb 2026 Form 4 Insider Report for RAYMOND JAMES FINANCIAL INC (RJF)

Role
Director
Signature
/s/ Marlene Debel by Jonathan J. Doyle as Attorney-in-Fact
Issuer symbol
RJF
Transactions as of
19 Feb 2026
Net transactions value
$0
Form type
4
Filing time
23 Feb 2026, 15:36:15 UTC
Previous filing
05 Mar 2025
Next filing
26 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
DEBEL MARLENE Director 880 CARILLON PARKWAY, ST. PETERSBURG /s/ Marlene Debel by Jonathan J. Doyle as Attorney-in-Fact 23 Feb 2026 0001770295

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RJF Common Stock Options Exercise $0 +1,253 +17% $0.000000 8,820 19 Feb 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RJF Restricted Stock Units Award $0 +1,303 +104% $0.000000 2,556 19 Feb 2026 Common Stock 1,303 Direct F1, F2
transaction RJF Restricted Stock Units Options Exercise $0 -1,253 -49% $0.000000 1,303 19 Feb 2026 Common Stock 1,253 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends.
F2 The award will vest at the date of the next succeeding annual shareholders meeting, but no later than March 15, 2027.
F3 The award vested in accordance with its terms, which provided for vesting at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant.

Remarks:

This Form 4 reports (i) the acquisition by the reporting person of RSUs resulting from an annual grant to the registrant's non-executive directors and (ii) the vesting of RSUs awarded to the reporting person.